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Plasmacytoid Dendritic Cells
Activate Lymphoid-Specific Genetic Programs
Irrespective of Their Cellular Origin
studies, and cell surface phenotypes (Shortman and Liu,
2002). In murine hematopoiesis, early studies showed
that CD11cMHCIICD11bCD8 “myeloid” DCs can
be efficiently derived from myeloid progenitors along
with granulocytes and macrophages (Inaba et al., 1993),
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phenotypes can originate both from the earliest myeloidHarvard Medical School
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et al., 2000]) and from the earliest lymphoid progenitors3 Department of Hematology/Oncology
(common lymphoid progenitors, CLPs [Kondo et al.,Children’s Hospital
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in pro-B cells or megakaryocyte/erythrocyte progenitorsKumamoto University
(MEPs) (Manz et al., 2001; Wu et al., 2001), although1-1-1 Honjo, Kumamoto 860-8556
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mental potential mainly resides within early granulocyte/Kyushu University Hospital
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Plasmacytoid dendritic cells (PDCs) were initiallyJapan
identified in humans (Cella et al., 1999; Grouard et al.,
1997; Jarrossay et al., 2001; Kadowaki et al., 2000, 2001).
These cells morphologically resemble antibody-secre-Summary
ting plasma cells and were therefore termed PDCs. Upon
activation, they quickly acquire mature DC morphologyThe developmental origin of type I interferon (IFN)-
and phenotype without significant cell proliferation (Liu,producing plasmacytoid dendritic cells (PDCs) is con-
2001; Shortman and Liu, 2002). PDCs secrete massivetroversial. In particular, the rearrangement of immuno-
amounts of type I interferons (IFN- and -) when stimu-globulin heavy chain (IgH) genes in murine PDCs and
lated by unmethylated CpG DNA or by viruses (Cella etthe expression of pre-T cell receptor  (pT) gene
al., 1999; Grouard et al., 1997; Jarrossay et al., 2001;by human PDCs were proposed as evidence for their
Kadowaki et al., 2000, 2001; Siegal et al., 1999) through
“lymphoid” origin. Here we demonstrate that PDCs
the function of Toll-like receptors such as TLR7 and
capable of IFN production develop efficiently from
TLR9 (Kadowaki et al., 2001) and are thus believed to
both myeloid- and lymphoid-committed progenitors. be critical mediators of antiviral immune response. PDCs
Rearranged IgH genes as well as RAG transcripts were also play a role in adaptive immunity by directing either
found in both myeloid- and lymphoid-derived PDCs. T helper cell type 1 (Th1) or Th2 development (Boonstra
The human pT transgenic reporter was activated in et al., 2003), as well as by generating T regulatory cells
both myeloid- and lymphoid-derived PDCs at a level that induce T cell tolerance (Gilliet and Liu, 2002). Re-
comparable to pre-T cells. PDCs were the only cell cently, a murine counterpart of human PDCs has been
population that activated murine RAG1 knockin and identified and shown to exhibit similar functional proper-
human pT transgenic reporters outside the lymphoid ties (Asselin-Paturel et al., 2001; Bjorck, 2001; Martin et
lineage. These results highlight a unique develop- al., 2002; Nakano et al., 2001). Like human PDCs, mouse
mental program of PDCs that distinguishes them from PDCs express high levels of CD45RA (B220) and low
other cell types including conventional dendritic cells. levels of MHC class II (MHCII). Mouse PDCs express
low levels of the dendritic cell marker CD11c, and the
Introduction majority of them are CD8. In addition, mouse PDCs
are Ly-6C, a myeloid cell marker recognized by the
Dendritic cells (DCs) are one of the most important cell Gr-1 antibody that also reacts with Ly-6G on mature
types in the immune system due to their unique ability to granulocytes and monocytes.
orchestrate an acquired immune response (Banchereau The lineage origin of PDCs is controversial. On the
one hand, murine PDCs have been reported to carryand Steinman, 1998). Murine DCs have been classified
rearranged immunoglobulin heavy chain (IgH) D-J butinto two populations, myeloid and lymphoid, on the basis
not T cell receptor (TCR) D-J loci (Corcoran et al.,of anatomic localization, cellular origin in transplantation
2003). Another apparently lymphoid characteristic of
PDCs is the expression of the pre-T cell receptor  (pT)*Correspondence: koichi_akashi@dfci.harvard.edu
in the human thymic PDCs (Bendriss-Vermare et al.,6These authors contributed equally to this work.
2001; Res et al., 1999). The pT protein pairs with the7Present address: Department of Microbiology, Columbia University,
New York, New York 10032. TCR chain to form the pre-TCR (Groettrup et al., 1993)
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and plays a critical role in the efficient generation of number of PDC progeny was obtained on day 15 in both
cases. In both CMP- and CLP-injected mice, CD11cmature T cells (Fehling et al., 1995). Thus, PDCs manifest
classical lineage markers of both T and B cells, which donor-derived progeny (CD45.2) in the spleen con-
tained a significant fraction of B220 PDCs as well aswas proposed to reflect their lymphoid past (Corcoran
et al., 2003). On the other hand, human PDCs can be B220 DCs (Figure 1A). PDC and DC development was
observed also in mice injected with 1  105 GMPs orgenerated at least from myeloid progenitors expressing
receptors for macrophage colony-stimulating factor 1  104 pro-T cells, whereas 1  105 MEPs or pro-B
cells did not give rise to detectable numbers of PDC or(M-CSF) (Olweus et al., 1996). Mice deficient in ICSBP,
a critical transcription factor for monocyte development DC subsets (Figure 1A and data not shown). Thus, PDC
development appears similar to conventional DC devel-(Tamura et al., 2000), display the loss of PDCs and
CD8 DCs (Aliberti et al., 2003; Schiavoni et al., 2002), opment (Manz et al., 2001; Traver et al., 2000; Wu et al.,
2001) in that they can be efficiently derived from bothwhich can be restored by enforced expression of ICSBP
(Tsujimura et al., 2003). A recent report showed that granulocyte/monocyte and early T lymphoid pathways.
A recent study showed that a circulating populationlymphoid progenitors give rise to cells of B220CD11clo
PDC phenotype more efficiently than myeloid progeni- expressing CD11c and B220 but not MHCII can give rise
to PDCs, CD8 DCs, and CD8 DCs (del Hoyo et al.,tors (D’Amico and Wu, 2003). In this study, however, the
function of the resulting cells was not evaluated. It is 2002). CD11cI-AbDC precursors expressing B220 and
CD11b were also found in the blood of mice injectedthus still unclear whether the lymphoid characteristics
of PDCs reflect their lymphoid origin. with CMPs or CLPs (Figure 1A, right). These CMP- or
CLP-derived CD11cI-Ab DC precursors gave rise toWe have identified and purified progenitors of myeloid
or lymphoid-restricted potentials including CMPs and B220CD11c PDCs in the culture with Flt-3L (Brawand
et al., 2002) for 2 days (data not shown), suggesting thatCLPs (Akashi et al., 2000; Kondo et al., 1997). In the
current study, we analyzed directly the PDC potentials at least a fraction of PDCs can originate from CMPs and
CLPs via the common DC precursor stage.of these progenitor populations. Our data show that
lymphoid-restricted CLPs and pro-T cells as well as Figure 1B shows phenotypic characteristics of CMP-
or CLP-derived PDCs and DCs. Within the CD11c DCmyeloid-restricted CMPs and GMPs can generate
IFN-producing PDCs with IgH D-J rearrangement. Fur- fraction in mice reconstituted with CMPs, Gr-1 expres-
sion was only found in B220 PDCs. CMP-derived PDCsthermore, recombination activation gene-1 (RAG1) tran-
scripts were found in both myeloid and lymphoid PDCs. expressed only negative to low levels of CD11b and DC
maturation/activation markers such as CD40, CD80, andThe majority of PDCs including CMP-derived PDCs acti-
vated RAG1 locus in mice carrying a knockin reporter CD86. A majority of PDCs expressed CD4 and CD8. In
both CMP- and CLP-derived PDCs, the expression levelfor murine RAG1. Furthermore, in transgenic mice car-
rying a human pT reporter construct, human pT was of I-Ab was relatively low as compared to B220 DCs.
Thus, phenotypic characteristics of CMP- and CLP-derivedstrongly activated in PDCs irrespective of their lymphoid
or myeloid origin. Taken together, our data demonstrate PDCs were identical to those of B220CD11c PDCs
isolated from the normal spleen (Figure 1B, bottom).that IFN-producing PDCs can originate from both
lymphoid and myeloid pathways and that the lymphoid Purified B220CD11c cells derived from CMPs or CLPs
produced significant amount of IFN- upon exposurecharacteristics of PDCs represent a unique “ectopic”
activation of the lymphoid programs. PDC-specific acti- to herpes simplex virus (HSV) in vitro, indicating that
they are functional PDCs (Figure 2A).vation of the human pT reporter in murine hematopoie-
sis in turn suggests that previously defined murine PDCs On a per cell basis, transplanted CMPs and CLPs
were more efficient than GMPs and pro-T cells for bothare faithful counterparts of human PDC subsets.
PDC and DC production (Table 1). CMPs and CLPs gave
rise to 2- to 3-fold higher numbers of conventional DCsResults
as compared to PDCs. Total mouse bone marrow cells
contains 10-fold more CMPs than CLPs. Accordingly,PDC Potentials of Murine Progenitors Correlate
the estimated contribution of myeloid progenitorswith Their Conventional DC Potentials
(CMPs and GMPs combined) to the PDC pool was95%We estimated the relative contribution of myeloid and
and 30% in the spleen and the thymus, respectivelylymphoid pathways to PDC development by in vivo re-
(Table 1).constitution assays. Myeloid- and lymphoid-committed
progenitors including CMPs, GMPs, and CLPs (CD45.2)
were purified and transplanted into C57B6-CD45.1 mice Comparison of Lineage-Specific Gene Expression
in Myeloid and Lymphoid PDCsalong with 300 host-type (CD45.1) Sca-1c-Kithemato-
poietic stem cells (HSCs) (Spangrude et al., 1988) to We next tested the myeloid or lymphoid characteristics
of CMP- and CLP-derived PDCs and DCs by evaluatingprovide radioprotection. Myeloid or lymphoid differenti-
ation potentials of these lineage-restricted progenitors lineage-related gene expression by semiquantitative
RT-PCR (Akashi et al., 2000). As shown in Figure 2B, allhave been described, previously (Akashi et al., 2000;
Kondo et al., 1997; Na Nakorn et al., 2002). We injected PDC and DC populations expressed Flt-3 and myeloid
cytokine receptors such as IL-3R and GM-CSFR at2 104 CLPs or CMPs, and analyzed their PDC progeny
on day 10, 15, and 20 on FACS by using the phenotypic similar levels. PDCs expressed higher levels of IL-7R,
an essential cytokine receptor for T and B cell develop-definition of Lineage (Lin: CD19, CD3, NK1.1, TCR, and
sIgM) -negative, B220, and CD11c (Asselin-Paturel et ment (Akashi et al., 1997; Peschon et al., 1994), regard-
less of their myeloid or lymphoid origin. Both lymphoid-al., 2001; Bjorck, 2001; Nakano et al., 2001). The highest
Ectopic Lymphoid Programs in Dendritic Cells
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Figure 1. Development of PDCs from Myeloid and Lymphoid Progenitors In Vivo
(A) DC analyses 15 days after transplantation of each purified progenitor subset are shown. Spleen cells were enriched for positive expression
of CD11c, and blood cells were enriched for negative expression of CD3 and CD19 prior to the phenotypic analyses (see Experimental
Procedures). Lin (CD19, CD3, NK1.1, TCR, and sIgM) CD45.2 cells in the spleen were analyzed for B220 and CD11c. Either transplanted
CMP, GMP, CLP, or pro-T cells differentiated into both PDCs and DCs in the spleen (left panels). The CD11cMHCII DC precursor population
was detectable in the Lin blood of mice reconstituted with CMPs or CLPs (right panels). CD11cMHCII DC precursors expressed B220
and CD11b.
(B) DC/PDC-related antigen expression of CMP- or CLP-derived PDCs (closed histogram) and conventional DCs (open histogram) is shown.
CMP, common myeloid progenitor; GMP, granulocyte/monocyte progenitor; CLP, common lymphoid progenitor; DCp, DC precursor.
and myeloid-derived PDCs expressed higher amounts CLP-derived PDCs at similar levels. Thus, the expres-
sion patterns of these dendritic cell-related genes wereof TLR9 (Kadowaki et al., 2001; Okada et al., 2003) which
recognizes unmethylated CpG DNA leading to IFN- similar in myeloid- and lymphoid-derived PDCs.
production.
PU.1 and RelB are essential for CD8 DC develop-
ment (Guerriero et al., 2000; Wu et al., 1998), whereas Myeloid- and Lymphoid-Derived PDCs
Rearrange IgH D-J LocusICSBP and Id2 are required for CD8 DC generation
(Aliberti et al., 2003; Hacker et al., 2003). ICSBP is essen- We then tested the rearrangement status of IgH D-J
genes in myeloid- and lymphoid-derived PDCs. Consis-tial also for PDC development (Schiavoni et al., 2002).
All of these transcription factors were expressed in both tent with a previous report (Corcoran et al., 2003), freshly
isolated PDCs but not DCs possessed IgH D-J rear-PDCs and DCs irrespective of their origin (Figure 2B).
Pax-5 and GATA-3, the master B and T lymphoid tran- rangements (Figure 2C, top). Purified Gr-1 or CD4
LinB220CD11c PDCs were also rearranged IgHscription factors, respectively (Nutt et al., 1997; Ting
et al., 1996), were not expressed in any DC or PDC genes (Figure 2C, bottom), indicating that the IgH rear-
rangements should not be due to contamination of Bpopulations. Spi-B, a myeloid/B lymphoid transcription
factor (Ray et al., 1992) was expressed only in PDCs cells within the B220CD11c PDC gate. TCR D-J
gene rearrangement was not detected in PDCs or DCsas previously reported (Bendriss-Vermare et al., 2001).
Notch-1, which plays a critical role in T cell commit- (data not shown). CMPs and CLPs did not rearrange
IgH genes (Figure 2C, top). Interestingly, a significantment and differentiation (Deftos et al., 2000; Robey,
1999), was expressed in PDCs at higher levels than DCs. fraction of both CMP-derived and CLP-derived PDCs
rearranged IgH D-J genes (Figure 2C, top), indicatingSpi-B and Notch-1 were expressed in both CMP- and
Immunity
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Figure 2. IFN Production and Gene Expression Profiles of PDCs and DCs of Myeloid or Lymphoid Origin
(A) IFN- levels in the supernatant of PDCs cultured with HSV. Note that only PDCs produce significant amounts of IFN- irrespective of their
lineal origin.
(B) RT-PCR analyses of lineage or differentiation related genes including cytokine receptors and transcription factors. The symbols under
each lane depict the relative amounts of transcripts in each population compared to control cDNA (2  105 cells) by the ratio of pixel density
units of target cDNA/pixel density units of control cDNA: 0.1 (), 0.1–0.5 (), 0.5–1.5 (), 1.5 ().
(C) D-J rearrangement of IgH gene in PDCs. IgH D-J rearrangement was detected by genomic PCR using primer sets for DHQ52 element.
Freshly isolated PDCs but not DCs, CMPs, or CLPs rearranged IgH D-J locus. Both CMP-derived PDCs (CMP-PDC) and CLP-derived PDCs
(CLP-PDC) rearranged at least at the JH2 locus of IgH (upper panels). Samples containing 300 freshly isolated Gr-1B220CD11c or
CD4B220CD11c PDCs also rearranged IgH genes (bottom).
that the rearrangement of IgH genes occurs during the in pre-T and pre-B cells. A fraction of NK (data not
transition from the CMP or CLP stages to mature PDC shown), T, and B cells maintained GFP expression. We
stage. Thus, IgH D-J rearrangements in PDCs do not found that the majority of spleen and thymic PDCs but
necessarily reflect their lymphoid origin but rather arise not DCs expressed a low level of GFP (Figure 3B). Inter-
during late stages of PDC development. estingly, in the analysis of the bone marrow and spleen,
the activation of RAG1-GFP outside the lymphoid (T, B,
and NK) system was only found in the PDC fraction.PDCs Activate RAG1 Transcription
GFP was also expressed in PDCs developed from CMPIrrespective of Their Origin
in vivo (Figure 3C), but CD11cMHCII DC precursorsSince the IgH rearrangements depend upon activation
in the blood did not express GFP (Figure 3A). RT-PCRof RAG, we hypothesized that RAG might be expressed
analyses showed that CMP- and CLP-derived PDCs, butin PDCs. To test this model, we analyzed mice carrying
not DCs, possessed RAG1 and RAG2 (data not shown)a reporter for RAG1 transcription, in which enhanced
transcripts (Figure 3D). The expression level of RAGgreen fluorescent protein (EGFP) is knocked into the
genes was low, since we could detect RAG1 and RAG2RAG1 locus (Kuwata et al., 1999). In heterozygous
transcripts in PDCs only by nested RT-PCR. Altogether,RAG1-EGFP knockin mice, the majority of CLPs and
these data suggest that the IgH rearrangements in PDCsproT cells expressed GFP, whereas there were no de-
result from the ectopic low-level expression of RAGtectable GFP cells in myeloid progenitors including
CMPs and GMPs (Figure 3A). GFP was highly expressed genes in the committed PDCs.
Ectopic Lymphoid Programs in Dendritic Cells
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PDCs Activate Human pT Transcription
Irrespective of Their Origin
In humans, pT is expressed in PDCs at a high level
comparable to thymocytes (Bendriss-Vermare et al.,
2001). In contrast, murine pT expression was barely
detectable in PDCs, and its level was significantly lower
than in thymocytes (Corcoran et al., 2003). By RT-PCR,
we could detect very low levels of murine pT transcripts
in both CLP- and CMP-derived PDCs (Figure 4A). Thus,
it has been suggested that pT expression may not
reflect their origin. Furthermore, this observation raised
the possibility that murine B220CD11c PDCs may not
represent the counterpart of human PDCs. Alternatively,
the transcriptional regulation of the human and murine
pT genes may be inherently different. To distinguish
between these possibilities, we again turned to the anal-
ysis of reporter mouse strains.
Normal transcriptional regulation of human genes has
been reproduced in transgenic mice that carry large
human genomic fragments such as yeast or bacterial
artificial chromosomes (BAC) (Kaufman et al., 1999;
Okuno et al., 2002; Peterson et al., 1993). Therefore, we
analyzed BAC transgenic mice carrying either mouse or
human pT loci in which the first exons were replaced
with an EGFP gene (Reizis and Leder, 1999, 2001). In
murine pT-EGFP transgenic mice, GFP expression was
restricted to lymphoid cells in the thymus and was
not found at detectable levels in spleen or bone mar-
row cells including PDCs (Figure 4B). In contrast, in
human pT-EGFP transgenic mice, GFP cells were
found in a significant fraction of thymic cells including
B220CD11c PDCs and immature thymocytes includ-
ing pro-T and pre-T cells (Figure 5A). Strikingly, in the
bone marrow and the spleen, GFP cells almost exclu-
sively displayed the B220CD11cPDC phenotype (Fig-
ure 5A). These results indicate that the human pT is
activated in PDCs during mouse hematopoiesis, possi-
bly due to some regulatory element specific to the hu-
man gene, and confirm that previously defined murine
PDCs (Asselin-Paturel et al., 2001; Bjorck, 2001; Nakano
et al., 2001) represent the human PDC counterpart.
The expression of the human pT transgene in PDCs
was heterogeneous, with the fraction of GFP PDCs
proportional to the transgene copy number (data not
shown). In the transgenic line analyzed, the expression
was found in 30% of PDCs in the thymus, spleen, and
bone marrow (Figure 5B). The expression patterns of
Gr-1, CD11b, MHCII (I-Aq), CD4, and CD8 were similar
between GFP and GFP PDCs (Figure 5B), and both
PDCs subsets produced IFN- upon HSV treatment (Fig-
ure 5C). Moreover, expression levels of lymphoid genes
such as IL-7R, Spi-B, and Notch-1 did not significantly
differ between GFP and GFP splenic PDCs (Figure 5D).
We next tested whether the activation of human pT
occurs specifically in lymphoid-derived PDCs. In human
pT-EGFP transgenic mice, GFP expression was initi-
ated at the CLP stage (Figure 6A): GFP cells were found
in 2% and 60% of CLPs and pre-T cells, respectively,
whereas myeloid progenitors such as CMPs and GMPs
did not express GFP. GFP was not upregulated in circu-
lating CD11cMHCII DC precursors (Figure 6A). GFP
CLPs and CMPs were purified from human pT-EGFP
transgenic mice and were transplanted into lethally irra-
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diated hosts. As shown in Figure 6A, both CMPs and
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Figure 3. Analysis of RAG1-EGFP Knockin Mice
(A) Expression of RAG1-EGFP in each purified progenitor subsets. DCp, DC precursors.
(B) Steady-state PDCs but not DCs were EGFP.
(C) RAG1-EGFP was expressed in CMP-derived PDCs in the spleen. EGFP expression was evaluated 15 days after transplantation of purified
EGFP CMPs into congenic hosts.
(D) The nested RT-PCR analysis of RAG1 in purified populations. Both CMP-derived PDCs (CMP-PDC) and CLP-derived PDCs (CLP-PDC)
possessed RAG1 transcripts.
CLPs gave rise to PDCs, which contained a similar pro- Discussion
portion (25%) of GFP cells in each case. Thus, human
pT transcription is upregulated after cells differentiate In this study, we provide a formal proof that functional
PDCs originate from both myeloid and lymphoid devel-into PDCs irrespective of their lineal origin.
Figure 4. Analysis of Murine pT Expression
in PDCs
(A) RT-PCR analyses of pT in purified PDC
and DC subsets. Both myeloid and lymphoid
PDCs express murine pT transcript albeit at
a very low level.
(B) Analysis of GFP cells in murine (m)
pT-EGFP transgenic mice. GFP expression
is only seen in B220CD11c immature thy-
mocytes, and none of the CD3CD19 spleen
and bone marrow cells express GFP at a de-
tectable level on FACS.
Ectopic Lymphoid Programs in Dendritic Cells
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Figure 5. Analysis of Mice Harboring a Human pT Transgenic Reporter
(A) Analysis of GFP cells in human pT-EGFP transgenic mice. In the thymus, the GFP population consists of B220CD11c PDCs as well
as B220CD11c immature thymocytes. In contrast, GFP cells are exclusively B220CD11c PDCs in the bone marrow and the spleen.
(B) GFP expression in PDCs and DCs in thymus, bone marrow, and spleen cells of human pT-EGFP transgenic mice (left panels). The
expression of other DC-related antigens in spleen PDCs and DCs is also shown (right panels). PDCs display the similar expression pattern
of these antigens regardless of human pT-EGFP transgene activation.
(C) IFN- levels in the supernatant of human pT-GFP-positive or -negative PDCs cultured with HSV.
(D) Expression profiles of lymphoid-related genes in human pT-GFP-positive or -negative PDCs. BM, bone marrow; hu-pT, human pT.
opmental pathways. PDC potential is maintained along et al., 2003). In this study, however, we did not subfrac-
tionate each progenitor population by Flt-3 expressionearly T lymphoid stages (i.e, CLPs and pro-T cells) and
early granulocyte/monocyte stages (i.e., CMPs and because Flt-3-negative subsets still could produce sig-
nificant numbers of DCs and PDCs (D’Amico and Wu,GMPs) (Figure 6B). CMP- and CLP-derived PDCs appear
equally functional, producing IFN- when challenged 2003). It is possible that Flt-3 expression represents
an immediate expansion potential of each progenitorwith a virus. Both CMPs and CLPs efficiently gave rise
to PDCs and DCs, and the frequency of PDC generation subset. By using purified myeloid and lymphoid progeni-
tors that include both Flt-3-positive and -negative sub-within total DC outputs from each progenitor was similar
(Table 1). Although a very small fraction (0.1%) of sets, we demonstrate here that the myeloid pathway
should produce the majority of PDCs, as in the case ofCMPs maintain B cell potential (Akashi et al., 2000),
PDCs and conventional DCs developed also from GMPs, conventional DCs (Table 1) (Manz et al., 2001).
Myeloid and lymphoid cells generally differentiatewhich are completely devoid of lymphoid potential.
Pro-B cells could not differentiate into either PDCs or along independent pathways, where CMPs and CLPs
likely represent the earliest committed branchpointsDCs. Thus, PDC potential is closely associated with
conventional DC potential (Manz et al., 2001; Traver et (Akashi et al., 2000; Kondo et al., 1997). Therefore, it was
conceivable that myeloid- or lymphoid-derived DC/PDCal., 2000) throughout the hematopoietic hierarchy. CMPs
and CLPs could be still heterogeneous for PDC and DC subsets might be phenotypically and functionally dis-
tinct. In this study, however, we could not find any appar-potential since Flt-3-expressing CMPs and CLPs were
reported to produce PDCs and DCs more efficiently than ent phenotypic or functional differences between my-
eloid- and lymphoid-derived subsets. Interestingly,Flt-3-negative ones (D’Amico and Wu, 2003; Karsunky
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Figure 6. Function and Origin of PDC Populations Segregated by the Activation of the Human pT Transgene
(A) The expression of human pT-EGFP in PDCs derived from CMPs or CLPs. In human pT-EGFP transgenic mice, pre-T cells but not CMPs
or CLPs upregulate GFP (upper panels). GFP CMPs and CLPs give rise to GFP PDCs in vivo after transplantation (bottom panels).
(B) Models of PDC and DC development from myeloid and lymphoid progenitors. According to the myeloid versus lymphoid developmental
scheme (Akashi et al., 2000; Kondo et al., 1997), myeloid progenitors (CMPs and GMPs) and lymphoid progenitors (CLPs and pro-T cells) give
rise to independent DC precursors (DCp), respectively (I), where DC and PDC populations should consist of myeloid and lymphoid subtypes.
In contrast, if myeloid and lymphoid progenitors use an identical pathway for DC development via common DCp (II), their DC and PDC progeny
should also be identical regardless of their original lineages. The induction of human pT and RAG1 expression has been proposed to occur
at late stages of PDC development from both lymphoid and myeloid progenitors in either model. HSC, hematopoietic stem cell.
myeloid-related cytokine receptors such as GM-CSFR By PCR analysis, the expression of pT in the mouse
PDCs appeared very low. Consistent with this, PDCs inand IL-3R were expressed in CLP-derived PDCs and
DCs at levels similar to CMP-derived ones, respectively, murine pT-EGFP mice did not express significant levels
of GFP, while pre-T cells had GFP at a very high level.suggesting the reactivation of these myeloid cytokine
receptors during the lymphoid to DC/PDC differentia- In human PDCs (Bendriss-Vermare et al., 2001), pT
levels are comparable to those observed in thymic T celltion. It is important to note that CLPs and pro-T cells can
be converted into mature granulocytes and monocytes precursors (Res et al., 1999). Indeed, the human pT
transgene was strongly expressed in a fraction of PDCs,simply by ectopic expression of GM-CSF signaling (Iwa-
saki-Arai et al., 2003; Kondo et al., 2000). In this context, as represented by the expression of GFP at levels com-
parable to thymic precursors (Figure 5). These expres-DCs and PDCs may develop from CLPs and pro-T cells
by using their residual myeloid differentiation programs sion patterns were observed in multiple independent
transgenic lines, including seven human pT-EGFP and(Iwasaki-Arai et al., 2003).
PDCs, however, also activate lymphoid programs dur- four mouse pT-EGFP lines (B.R. et al., unpublished
data). Therefore, the significant upregulation of pT ining their development from myeloid and lymphoid pro-
genitors. Indeed, B/myeloid-related Spi-B as well as T PDCs appears to result from properties intrinsic to the
human pT gene. Our analysis showed that similar per-lymphoid-related Notch-1 was expressed at higher lev-
els in CMP- and CLP-derived PDCs than conventional centages of CMP- and CLP-derived PDCs activated the
human pT transgene, and both human pT and pTDCs (Figure 2B). Moreover, IgH rearrangement was de-
tected in both myeloid- and lymphoid-derived PDCs PDCs can produce equal amounts of IFN-. Further-
more, when we crossed human pT transgenic mice(Figure 2C). Importantly, PDCs were the only cell types
that expressed GFP outside the lymphoid lineage in with athymic nu/nu mice, PDCs in athymic human-
pT-EGFP transgenic mice also became GFP (B.R. etRAG1-GFP mice (Figure 3), and both lymphoid and my-
eloid PDCs possessed RAG1 and RAG2 transcripts, al- al., unpublished data). This indicates that the pT activa-
tion does not require thymic T cell maturation or expo-though their expression levels were lower than lymphoid
progenitors. Thus, the ectopic activation of RAG genes sure to thymic microenvironments and is therefore inde-
pendent of T cell development. Taken together, ourin both myeloid- and lymphoid-derived PDCs might re-
sult in the rearrangement of IgH genes. Another impor- results show that the expression of the human pT by
PDCs does not reflect their derivation from lymphoidtant lymphoid marker, pT, is also expressed in both
CLP- and CMP-derived PDCs, although their expression precursors. The fact that the activation of human-
pT-EGFP reporter occurs exclusively in PDCs outsidelevels were low as compared to thymocytes (Figure 4).
It remains to be established whether the activation of the lymphoid system suggests that the phenotypically
defined murine PDCs (Asselin-Paturel et al., 2001;these lymphoid developmental programs is in any way
relevant for the unique functions of PDCs. Bjorck, 2001; Martin et al., 2002; Nakano et al., 2001)
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Experimental Proceduresfully correspond to the human PDC counterpart (Cella
et al., 1999; Grouard et al., 1997; Jarrossay et al., 2001;
MiceKadowaki et al., 2000).
C57B6 (CD45.1 or CD45.2) mice were purchased from The Jackson
It is important to note that the GFP protein might Laboratory (Bar Harbor, ME). RAG1-EGFP knockin mice have been
degrade at a slower rate as compared to native proteins, described elsewhere (Igarashi et al., 2001; Kuwata et al., 1999).
Human or murine pT-EGFP transgenic mice (FVB-CD45.1) wereand therefore, the low level of GFP expression in PDCs
described previously (Reizis and Leder, 1999, 2001). F1 (FVB-could represent the RAG1 activation at a developmental
CD45.1xC57B6-CD45.2) mice were used as hosts for transplantationstage prior to the PDC stage. Both CMPs and CLPs
of pT-EGFP transgenic cells. To generate pT bacterial artificial
generate CD11cMHCII DC precursors (del Hoyo et chromosome transgenic mice, BAC clones containing either mouse
al., 2002) (Figure 1A), which further differentiate into both or human pT loci (90 and 113 kb, respectively) were modified to
replace the first pT exon with an enhanced green fluorescent pro-PDCs and conventional DCs in vitro (H.S. et al., unpub-
tein gene (Reizis and Leder, 1999, 2001). The upstream pT enhancerlished data). The RAG1 or the human pT reporter, how-
was left intact. The resulting BAC clones were used to generateever, was not activated in the DC precursors, and the
multiple independent transgenic mouse lines, which manifested
level of RAG1 transcripts was very low in mature PDCs. copy number-dependent EGFP expression with the same pattern
It is thus possible that these lymphoid genes are mainly for each construct (data not shown). One line derived from each
activated during the transition from the DC precursor to BAC with a similarly high transgene copy number (16–17 copies in
hemizygous state as determined by quantitative genomic Southernmature PDC stages (Figure 6B). Furthermore, although
hybridization) was chosen for detailed analysis. Mice were bred andit remains unknown whether all DCs and PDCs are gen-
maintained in the Research Animal Facilities at the Dana Farbererated from the DC precursor population, the capability Cancer Institute or Harvard Medical School, in accordance with
of CMPs and CLPs to generate DC precursors suggests institutional guidelines.
the existence of the common DC/PDC pathway, where
myeloid and lymphoid DC pathways merge together at
Sorting of Progenitors and Dendritic Cells
the common DC precursor stage to give rise to mature Sorting of myeloid progenitors was accomplished by staining bone
DCs and PDCs (Figure 6B, bottom). In this model, equiv- marrow cells with purified rat anti-IL-7R chain monoclonal antibod-
ies (A7R34) (eBioscience, San Diego, CA) and purified or PE-Cy5-alent DC subsets may thus be independently generated
conjugated rat antibodies specific for the following lineage markers:by both lineal pathways, and this may explain our inabil-
CD3 (CT-CD3), CD4 (RM4-5), CD8 (5H10), B220 (6B2), Gr-1 (8C5),ity to detect unique DC attributes from each pathway.
Ter119, and CD19 (6D5) (Caltag, Burlingame, CA). IL-7RLin cells
If early lymphocyte-specific genes such as RAG and were removed with sheep anti-rat IgG-conjugated magnetic beads
pT are unlikely to play any role in PDC function, why (Dynabeads M-450; Dynal A.S., Oslo, Norway), and the remaining
are they expressed in mature PDCs? Since PDCs are cells were stained with PE-Cy5-conjugated goat anti-rat IgG (Cal-
tag). Cells were then stained with PE-conjugated anti-Fc	RII/IIIpart of the innate immune system, they are likely to
(2.4G2), FITC-conjugated anti-CD34 (RAM34), APC-conjugated anti-predate antigen receptor-bearing lymphocytes in evolu-
c-Kit (2B8), and biotinylated anti-Sca-1 (E13-161-7) monoclonal anti-tion. Therefore, the genetic program of their develop-
bodies (Pharmingen, San Diego, CA), followed by avidin-APC-Cy7
ment would be more ancient than that of lymphocytes (Caltag). Myeloid progenitors were sorted as IL-7RLinSca-1
and may represent a “prototype” genetic pathway of im- c-KitCD34Fc	RII/IIIlo (CMPs), IL-7RLinSca-1c-KitCD34
Fc	RII/IIIhi (GMPs), and IL-7RLinSca-1c-KitCD34-Fc	RII/IIIlomune cell development. Later in evolution, parts of such a
(MEPs) as described previously (Akashi et al., 2000). HSCs and CLPspathway could be utilized in the development of specific
were sorted as IL-7RLinSca-1hic-Kithi and IL-7RLinSca-1lolineages such as T and B lymphocytes. It is tempting to
c-Kitlo populations, respectively (Kondo et al., 1997). Pro-T and pro-B
speculate that the expression of early lymphocyte genes cells were sorted as CD3CD4CD8NK1.1IL-7Rc-KitCD25
in PDCs reflects the ancient mechanisms of transcriptional and CD43B220IgMNK1.1 cells, respectively.
DCs were isolated from spleen, thymus, and bone marrow ascontrol that can activate both lymphoid- and myeloid-
described elsewhere (Manz et al., 2001; Wu et al., 2001). In brief,specific genes during PDC development. The character-
spleens and thymi were cut into small fragments and digested withization of these mechanisms of gene expression in PDCs
collagenase and DNase under repeated agitation, followed by the
should be a focus of future experimentation. addition of EDTA. Enzymatic digestion was avoided when isolating
In conclusion, our data demonstrate that the gene DCs from bone marrow samples. To enrich DC populations, CD11c
expression program of PDCs is unique and includes the cells were positively enriched with CD11c (N418) MicroBeads and
MACS separation columns (Miltenyi Biotec, Bergisch Gladbach,activation of both myeloid- and lymphoid-related genes.
Germany). In some experiments, DCs were enriched after immuno-In particular, mature PDCs express at least some genetic
magnetic depletion of B cells and T cells with anti-CD19 (6D5), anti-programs primarily associated with early lymphocyte IgM (1B4B1), anti-CD3 (CT-CD3), and sheep anti-rat IgG-conjugated
development, including RAG and pT transcripts and magnetic beads (Dynal). Cells were stained with anti-CD11c (HL3)
rearranged IgH genes. This lymphoid program is inde- and anti-B220 (RA3-6B2) as well as a lineage cocktail including anti-
CD3 (CT-CD3), anti-TCR (H57-597), anti-CD19 (6D5) (Caltag), anti-pendent of the cellular origin of PDCs, as it is observed
IgM (1B4B1) (eBioscience), and anti-NK1.1 (PK136) (Pharmingen).in PDCs derived from both myeloid and lymphoid pro-
PDCs and DCs were purified as LinB220CD11c cells andgenitors. Therefore, it is likely to reflect specific tran-
LinB220CD11c cells, respectively. These DC populations were
scriptional mechanisms operating in committed PDCs further analyzed by anti-Gr-1 (RB6-8C5), anti-CD11b (M1/70), anti-
rather than their affiliation with the lymphoid lineage. CD4 (GK1.5), anti-CD8 (53-6.7), anti-I-Ab (AF6-120.1), anti-CD40
(3/23), anti-CD80 (16-10A1), anti-CD86 (GL1), and anti-I-Aq (KH116).The expression of early lymphoid genes appears as a
Streptavidin-conjugated PE, Cy5-PE, and APC-Cy7 (Caltag) wereunique property of PDCs that clearly distinguishes them
used to visualize biotinylated antibodies.from other mature cell types in the immune system.
Cells were sorted using a highly modified double laser (488 nm/350
Future studies should elucidate the molecular basis and nm Enterprise II  647 nm Spectrum) high-speed FACS (Moflo-
possible functional significance of lymphoid gene ex- MLS, Cytomation, Fort Collins, CO). Data were analyzed with FlowJo
software (Treestar, Inc., San Carlos, CA).pression in PDCs.
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Measurement of IFN- from PDCs Ardavin, C., Wu, L., Li, C.-L., and Shortman, K. (1993). Thymic den-
dritic cells and T cells develop simultaneously in the thymus fromFACS-purified B220CD11c PDCs and B220CD11c DCs were
cultured with HSV (10 pfu/cell) in IMDM supplemented with 10% a common precursor population. Nature 362, 761–763.
fetal calf serum (FCS) and 104 M 2-mercaptoethanol. Culture super- Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad,
natants were collected 24 hr after the initiation of cultures and were N., Dezutter-Dambuyant, C., Vicari, A., O’Garra, A., Biron, C., Briere,
analyzed by mouse IFN- ELISA kit (Performance Biomedical Labo- F., and Trinchieri, G. (2001). Mouse type I IFN-producing cells are
ratories, New Brunswick, NJ). immature APCs with plasmacytoid morphology. Nat. Immunol. 2,
1144–1150.
In Vivo Reconstitution Assays
Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and thePurified progenitors (CD45.2) from C57B6 or RAG1-GFP knockin
control of immunity. Nature 392, 245–252.(C57B6) mice were intravenously transplanted into congenic mice
Bendriss-Vermare, N., Barthelemy, C., Durand, I., Bruand, C., Dezut-(CD45.1) after a lethal dose (950 rad) of irradiation, together with
ter-Dambuyant, C., Moulian, N., Berrih-Aknin, S., Caux, C., Trinchieri,300 Sca-1c-Kit host-type (CD45.1) stem cells to provide radiopro-
G., and Briere, F. (2001). Human thymus contains IFN-alpha-produc-tection. Mice were sacrificed on day 15, and donor-derived progeny
ing CD11c(), myeloid CD11c(), and mature interdigitating den-were analyzed using the CD45.2 donor marker. For reconstitution
dritic cells. J. Clin. Invest. 107, 835–844.assays of human pT-EGFP transgenic progenitors (FVB-CD45.1),
GFP CMPs or CLPs were injected intravenously into F1 (FVB- Bjorck, P. (2001). Isolation and characterization of plasmacytoid
CD45.1xC57B6-CD45.2) mice with 300 Sca-1c-Kit stem cells of F1 dendritic cells from Flt3 ligand and granulocyte-macrophage col-
mice. Donor-derived cells were detected as CD45.1CD45.2 cells. ony-stimulating factor-treated mice. Blood 98, 3520–3526.
Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G.,Analysis of Gene Expression from Total RNA
Liu, Y.J., and O’Garra, A. (2003). Flexibility of mouse classical andTotal RNA was extracted from 1000 purified cells for each population
plasmacytoid-derived dendritic cells in directing T helper type 1 andand was reverse transcribed to cDNA (Akashi et al., 2000). An aliquot
2 cell development: dependency on antigen dose and differentialof cDNA was analyzed for specific genes. PCR products were sub-
toll-like receptor ligation. J. Exp. Med. 197, 101–109.jected to electrophoresis on a 1.8% agarose gel, followed by ethid-
ium bromide staining. PCR amplification for each experiment was Brawand, P., Fitzpatrick, D.R., Greenfield, B.W., Brasel, K., Malis-
repeated for two or more independently prepared cDNA samples. zewski, C.R., and De Smedt, T. (2002). Murine plasmacytoid pre-
Relative gene expression quantification was accomplished by com- dendritic cells generated from Flt3 ligand-supplemented bone mar-
paring the level of any transcript in the target samples to that in row cultures are immature APCs. J. Immunol. 169, 6711–6719.
control cDNA prepared from 2  105 whole bone marrow cells or Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H.,
thymocytes (Akashi et al., 2000). PCR cycles for each target gene Lanzavecchia, A., and Colonna, M. (1999). Plasmacytoid monocytes
were at a point when the reaction was in the exponential phase to migrate to inflamed lymph nodes and produce large amounts of
obtain a linear correlation between pixel density units of the PCR type I interferon. Nat. Med. 5, 919–923.
product and the amount of control cDNA (Akashi et al., 2000). Primer
Corcoran, L., Ferrero, I., Vremec, D., Lucas, K., Waithman, J.,sequences for each specific gene are shown in Supplemental Table
O’Keeffe, M., Wu, L., Wilson, A., and Shortman, K. (2003). TheS1 at http://www.immunity.com/cgi/content/full/21/1/43/DC1.
lymphoid past of mouse plasmacytoid cells and thymic dendritic
cells. J. Immunol. 170, 4926–4932.IgH Gene Rearrangement Analysis
Genomic DNA was extracted from 4000 double-sorted cells by incu- D’Amico, A., and Wu, L. (2003). The early progenitors of mouse
bation at 56
C for 45 min in 50 l of 1 PCR buffer containing 0.5% dendritic cells and plasmacytoid predendritic cells are within the
Tween 20 and 100 g/ml proteinase K, followed by 10 min at 94
C bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med.
to inactivate proteinase K. PCR primers specific for DHQ52 element 198, 293–303.
were used to amplify rearranged IgH D-J as described previously
Deftos, M.L., Huang, E., Ojala, E.W., Forbush, K.A., and Bevan, M.J.
(ten Boekel et al., 1995). PCR products were separated on an aga-
(2000). Notch1 signaling promotes the maturation of CD4 and CD8rose gel, transferred onto nylon membranes, and subjected to
SP thymocytes. Immunity 13, 73–84.Southern blotting using standard procedures. To detect TCR rear-
del Hoyo, G.M., Martin, P., Vargas, H.H., Ruiz, S., Arias, C.F., andrangement, the extracted DNA was amplified with the primers for
Ardavin, C. (2002). Characterization of a common precursor popula-D1-J1 and D2-J2 as reported (Iwasaki-Arai et al., 2003).
tion for dendritic cells. Nature 415, 1043–1047.
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